The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?
Expert Review of Clinical Pharmacology · 2024
DOI: 10.1080/17512433.2024.2396119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2024. Verfasst von Julie Wacker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Hypertension Program, University Hospitals of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Caregivers, Clinical Trials as Topic, Research Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Pediatric pulmonary hypertension is a rare condition. Survival remains poor in the current management era. There is a lack of data regarding the medical management of pediatric pulmonary hypertension and most pulmonary vasodilators are used off-label in children. AREAS COVERED: Pediatric pulmonary hypertension clinical trials' design and realization face many hurdles, including poor recruitment, limited available pharmacologic and physiologic data in children of various ages, ethical issues, and the lack of validated trial endpoint. Innovative clinical trial designs have emerged and may allow us to overcome some of these issues. Extrapolation of adult data to children, with additional pharmacokinetic and safety data, remains extremely important and valid in etiologies where the pediatric and the adult pathophysiologies are believed to be similar. EXPERT OPINION: Close collaboration between sponsors, regulators, patients, caregivers, physicians and researchers is necessary to develop efficacious and safe drugs for pediatric pulmonary hypertension. The increasing involvement of patients' and caregivers' participation in the development of clinical trials should help shape future research that is feasible and meaningful to the patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonary Hypertension Program, University Hospitals of Geneva, Geneva, Switzerland.
- Pediatric Cardiology Unit, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
- Division of Pulmonary Medicine, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
ORCID-Profile: Julie Wacker, Maurice Beghetti
Zitieren
APA
Wacker, J., Joye, R., Genecand, L., Lador, F., & Beghetti, M. (2024). The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2024.2396119
Vancouver
Wacker J, Joye R, Genecand L, Lador F, Beghetti M. The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?. Expert Review of Clinical Pharmacology. 2024. doi:10.1080/17512433.2024.2396119
BibTeX
@article{Wacker2024,
author = {Wacker, Julie and Joye, Raphael and Genecand, Leon and Lador, Frederic and Beghetti, Maurice},
title = {The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?},
journal = {Expert Review of Clinical Pharmacology},
year = {2024},
doi = {10.1080/17512433.2024.2396119}
}
EUVIMED